Abcam PLC is a biotechnology business based in the US. Abcam PLC shares (ABCM) are listed on the NASDAQ and all prices are listed in US Dollars. Abcam PLC employs 1,760 staff and has a trailing 12-month revenue of around $379.7 million.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $22.55 |
|---|---|
| 52-week range | $12.48 - $25.32 |
| 50-day moving average | $23.16 |
| 200-day moving average | $17.61 |
| Wall St. target price | $24.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0.75%) |
| Earnings per share (TTM) | $-0.05 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $22.55 from 2023-09-22
| 1 week (2023-09-18) | -0.44% |
|---|---|
| 1 month (2023-08-25) | -3.47% |
| 3 months (2023-06-23) | -1.83% |
| 6 months (2023-03-24) | 73.73% |
| 1 year (2022-09-23) | 54.14% |
|---|---|
| 2 years (2021-09-24) | 8.62% |
| 3 years (2020-09-21) | N/A |
| 5 years (2018-09-21) | N/A |
Valuing Abcam PLC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abcam PLC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
To put Abcam PLC's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $379.7 million |
|---|---|
| Operating margin TTM | 19.07% |
| Gross profit TTM | $270.5 million |
| Return on assets TTM | 4.33% |
| Return on equity TTM | 0.35% |
| Profit margin | 0.66% |
| Book value | $3.13 |
| Market Capitalization | $5.2 billion |
TTM: trailing 12 months
We're not expecting Abcam PLC to pay a dividend over the next 12 months.
You may also wish to consider:
Abcam PLC's shares were split on a 5:1 basis on 1 December 2010. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Abcam PLC shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Abcam PLC shares which in turn could have impacted Abcam PLC's share price.
Over the last 12 months, Abcam PLC's shares have ranged in value from as little as $12.48 up to $25.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcam PLC's is 0.9235. This would suggest that Abcam PLC's shares are less volatile than average (for this exchange).
To put Abcam PLC's beta into context you can compare it against those of similar companies.
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. .
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.